{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:30:20Z","timestamp":1793053820476,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04437-w","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:27:43Z","timestamp":1780036063000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Advances in the molecular subtyping of gastric cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Jiayi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xijie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhou","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"12","key":"4437_CR1","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.3748\/wjg.v28.i12.1187","volume":"28","author":"M Ilic","year":"2022","unstructured":"Ilic M, Ilic I. Epidemiology of stomach cancer. World J Gastroenterol. 2022;28(12):1187\u2013203.","journal-title":"World J Gastroenterol"},{"key":"4437_CR2","first-page":"103411","volume":"75","author":"GM Mranda","year":"2022","unstructured":"Mranda GM, et al. Revisiting the 8th AJCC system for gastric cancer: A review on validations, nomograms, lymph nodes impact, and proposed modifications. Ann Med Surg (Lond). 2022;75:103411.","journal-title":"Ann Med Surg (Lond)"},{"issue":"6 Suppl","key":"4437_CR3","first-page":"S3","volume":"58","author":"The Paris endoscopic","year":"2003","unstructured":"The Paris endoscopic. classification of superficial neoplastic lesions: esophagus, stomach, and colon: November 30 to December 1, 2002. Gastrointest Endosc. 2003;58(6 Suppl):S3\u201343.","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"4437_CR4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10120-011-0041-5","volume":"14","author":"Japanese classification of gastric carcinoma","year":"2011","unstructured":"Japanese classification of gastric carcinoma. 3rd English edition. Gastric Cancer. 2011;14(2):101\u201312.","journal-title":"Gastric Cancer"},{"issue":"1","key":"4437_CR5","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s12957-020-01987-5","volume":"18","author":"XH Song","year":"2020","unstructured":"Song XH, et al. Prognostic impact of Borrmann classification on advanced gastric cancer: a retrospective cohort from a single institution in western China. World J Surg Oncol. 2020;18(1):204.","journal-title":"World J Surg Oncol"},{"issue":"4","key":"4437_CR6","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00428-022-03392-7","volume":"481","author":"V Angerilli","year":"2022","unstructured":"Angerilli V, et al. Molecular subtyping of gastroesophageal dysplasia heterogeneity according to TCGA\/ACRG classes. Virchows Arch. 2022;481(4):545\u201352.","journal-title":"Virchows Arch"},{"issue":"2","key":"4437_CR7","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/his.13975","volume":"76","author":"ID Nagtegaal","year":"2020","unstructured":"Nagtegaal ID, et al. The 2019 WHO classification of tumours of the digestive system. Histopathology. 2020;76(2):182\u20138.","journal-title":"Histopathology"},{"issue":"5","key":"4437_CR8","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.3892\/ol.2016.4337","volume":"11","author":"J Ma","year":"2016","unstructured":"Ma J, et al. Lauren classification and individualized chemotherapy in gastric cancer. Oncol Lett. 2016;11(5):2959\u201364.","journal-title":"Oncol Lett"},{"key":"4437_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","volume":"64","author":"P Lauren","year":"1965","unstructured":"Lauren P. OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965;64:31\u201349. THE TWO HISTOLOGICAL MAIN TYPES.","journal-title":"Acta Pathol Microbiol Scand"},{"key":"4437_CR10","doi-asserted-by":"crossref","unstructured":"Bumgarner R. Overview of DNA microarrays: types, applications, and their future. Curr Protoc Mol Biol. 2013 Chapter 22: p. Unit 22.1.","DOI":"10.1002\/0471142727.mb2201s101"},{"issue":"7517","key":"4437_CR11","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/nature13480","volume":"513","author":"Comprehensive molecular characterization of gastric adenocarcinoma","year":"2014","unstructured":"Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513(7517):202\u20139.","journal-title":"Nature"},{"issue":"15","key":"4437_CR12","doi-asserted-by":"publisher","first-page":"4441","DOI":"10.1158\/1078-0432.CCR-16-2211","volume":"23","author":"BH Sohn","year":"2017","unstructured":"Sohn BH, et al. Clinical Significance of Four Molecular Subtypes of Gastric Cancer Identified by The Cancer Genome Atlas Project. Clin Cancer Res. 2017;23(15):4441\u20139.","journal-title":"Clin Cancer Res"},{"key":"4437_CR13","doi-asserted-by":"publisher","first-page":"102737","DOI":"10.1016\/j.ctrv.2024.102737","volume":"127","author":"J Bos","year":"2024","unstructured":"Bos J, et al. The tumor immune composition of mismatch repair deficient and Epstein-Barr virus-positive gastric cancer: A systematic review. Cancer Treat Rev. 2024;127:102737.","journal-title":"Cancer Treat Rev"},{"key":"4437_CR14","doi-asserted-by":"crossref","unstructured":"Tirino G, et al. What\u2019s new in gastric cancer: the therapeutic implications of molecular classifications and future perspectives. Int J Mol Sci. 2018;19(9):2659.","DOI":"10.3390\/ijms19092659"},{"issue":"10","key":"4437_CR15","first-page":"5006","volume":"11","author":"Y-T Sun","year":"2021","unstructured":"Sun Y-T, et al. PD-1 antibody camrelizumab for Epstein-Barr virus-positive metastatic gastric cancer: a single-arm, open-label, phase 2 trial. Am J Cancer Res. 2021;11(10):5006.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"4437_CR16","doi-asserted-by":"publisher","first-page":"22636","DOI":"10.1038\/s41598-021-02168-4","volume":"11","author":"M Hinata","year":"2021","unstructured":"Hinata M, Ushiku T. Detecting immunotherapy-sensitive subtype in gastric cancer using histologic image-based deep learning. Sci Rep. 2021;11(1):22636.","journal-title":"Sci Rep"},{"issue":"5","key":"4437_CR17","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/nm.3850","volume":"21","author":"R Cristescu","year":"2015","unstructured":"Cristescu R, et al. Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes. Nat Med. 2015;21(5):449\u201356.","journal-title":"Nat Med"},{"key":"4437_CR18","doi-asserted-by":"publisher","first-page":"153797","DOI":"10.1016\/j.prp.2022.153797","volume":"231","author":"E Pretzsch","year":"2022","unstructured":"Pretzsch E, et al. Molecular subtyping of gastric cancer according to ACRG using immunohistochemistry \u2013 Correlation with clinical parameters. Pathol - Res Pract. 2022;231:153797.","journal-title":"Pathol - Res Pract"},{"key":"4437_CR19","unstructured":"Tan IB, et al. Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy. (1528\u20130012 (Electronic))."},{"issue":"3","key":"4437_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1053\/j.gastro.2013.05.010","volume":"145","author":"Z Lei","year":"2013","unstructured":"Lei Z, et al. Identification of Molecular Subtypes of Gastric Cancer With Different Responses to PI3-Kinase Inhibitors and 5-Fluorouracil. Gastroenterology. 2013;145(3):554\u201365.","journal-title":"Gastroenterology"},{"issue":"9","key":"4437_CR21","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1158\/1078-0432.CCR-10-2203","volume":"17","author":"MA Shah","year":"2011","unstructured":"Shah MA, et al. Molecular Classification of Gastric Cancer: A New Paradigm. Clin Cancer Res. 2011;17(9):2693\u2013701.","journal-title":"Clin Cancer Res"},{"issue":"7","key":"4437_CR22","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1158\/0008-5472.CAN-15-2443","volume":"76","author":"X Li","year":"2016","unstructured":"Li X, et al. Distinct Subtypes of Gastric Cancer Defined by Molecular Characterization Include Novel Mutational Signatures with Prognostic Capability. Cancer Res. 2016;76(7):1724\u201332.","journal-title":"Cancer Res"},{"issue":"6","key":"4437_CR23","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1007\/s10120-021-01201-9","volume":"24","author":"H Wang","year":"2021","unstructured":"Wang H, et al. A novel genomic classification system of gastric cancer via integrating multidimensional genomic characteristics. Gastric Cancer. 2021;24(6):1227\u201341.","journal-title":"Gastric Cancer"},{"issue":"1","key":"4437_CR24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/s10120-021-01242-0","volume":"25","author":"K Furukawa","year":"2022","unstructured":"Furukawa K, et al. Molecular classification of gastric cancer predicts survival in patients undergoing radical gastrectomy based on project HOPE. Gastric Cancer. 2022;25(1):138\u201348.","journal-title":"Gastric Cancer"},{"issue":"10","key":"4437_CR25","doi-asserted-by":"publisher","first-page":"e1194","DOI":"10.1002\/cti2.1194","volume":"9","author":"Y Sato","year":"2020","unstructured":"Sato Y, et al. Integrative immunogenomic analysis of gastric cancer dictates novel immunological classification and the functional status of tumor-infiltrating cells. Clin Transl Immunol. 2020;9(10):e1194.","journal-title":"Clin Transl Immunol"},{"key":"4437_CR26","doi-asserted-by":"publisher","first-page":"685992","DOI":"10.3389\/fimmu.2021.685992","volume":"12","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning. Front Immunol. 2021;12:685992.","journal-title":"Front Immunol"},{"issue":"11","key":"4437_CR27","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1136\/gutjnl-2022-329134","volume":"72","author":"LL Cao","year":"2023","unstructured":"Cao LL, et al. Multivalent tyrosine kinase inhibition promotes T cell recruitment to immune-desert gastric cancers by restricting epithelial-mesenchymal transition via tumour-intrinsic IFN-\u03b3 signalling. Gut. 2023;72(11):2038\u201350.","journal-title":"Gut"},{"issue":"1","key":"4437_CR28","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1186\/s12885-021-09065-z","volume":"21","author":"S Zhang","year":"2021","unstructured":"Zhang S, et al. Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature. BMC Cancer. 2021;21(1):1324.","journal-title":"BMC Cancer"},{"issue":"1","key":"4437_CR29","doi-asserted-by":"publisher","first-page":"100888","DOI":"10.1016\/j.tranon.2020.100888","volume":"14","author":"Z Liu","year":"2021","unstructured":"Liu Z, et al. Classification of gastric cancers based on immunogenomic profiling. Transl Oncol. 2021;14(1):100888.","journal-title":"Transl Oncol"},{"issue":"1","key":"4437_CR30","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41525-021-00249-x","volume":"6","author":"Y Lin","year":"2021","unstructured":"Lin Y, et al. Immune cell infiltration signatures identified molecular subtypes and underlying mechanisms in gastric cancer. NPJ Genom Med. 2021;6(1):83.","journal-title":"NPJ Genom Med"},{"issue":"1","key":"4437_CR31","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1038\/s41467-018-04179-8","volume":"9","author":"SC Oh","year":"2018","unstructured":"Oh SC, et al. Clinical and genomic landscape of gastric cancer with a mesenchymal phenotype. Nat Commun. 2018;9(1):1777.","journal-title":"Nat Commun"},{"key":"4437_CR32","doi-asserted-by":"publisher","first-page":"939836","DOI":"10.3389\/fimmu.2022.939836","volume":"13","author":"G Wang","year":"2022","unstructured":"Wang G, et al. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer. Front Immunol. 2022;13:939836.","journal-title":"Front Immunol"},{"issue":"1","key":"4437_CR33","doi-asserted-by":"publisher","first-page":"4851","DOI":"10.1038\/s41467-022-32570-z","volume":"13","author":"Y Chen","year":"2022","unstructured":"Chen Y, et al. Predicting response to immunotherapy in gastric cancer via multi-dimensional analyses of the tumour immune microenvironment. Nat Commun. 2022;13(1):4851.","journal-title":"Nat Commun"},{"issue":"1","key":"4437_CR34","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12916-025-03889-3","volume":"23","author":"Y Xie","year":"2025","unstructured":"Xie Y, et al. Immune microenvironment spatial landscapes of tertiary lymphoid structures in gastric cancer. BMC Med. 2025;23(1):59.","journal-title":"BMC Med"},{"issue":"5","key":"4437_CR35","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(18)30108-6","volume":"19","author":"JH Cheong","year":"2018","unstructured":"Cheong JH, et al. Predictive test for chemotherapy response in resectable gastric cancer: a multi-cohort, retrospective analysis. Lancet Oncol. 2018;19(5):629\u201338.","journal-title":"Lancet Oncol"},{"issue":"4","key":"4437_CR36","doi-asserted-by":"publisher","first-page":"368","DOI":"10.21147\/j.issn.1000-9604.2024.04.02","volume":"36","author":"J Yeong An","year":"2024","unstructured":"Yeong An J, et al. A pilot clinical study to evaluate feasibility of using single patient classifier as a prognostic test in stage II\u2009\u2013\u2009III gastric cancer patients. Chin J Cancer Res. 2024;36(4):368\u201377.","journal-title":"Chin J Cancer Res"},{"issue":"9","key":"4437_CR37","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/s43018-021-00240-6","volume":"2","author":"Y Tanaka","year":"2021","unstructured":"Tanaka Y, et al. Multi-omic profiling of peritoneal metastases in gastric cancer identifies molecular subtypes and therapeutic vulnerabilities. Nat Cancer. 2021;2(9):962\u201377.","journal-title":"Nat Cancer"},{"issue":"1","key":"4437_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/s41467-022-28437-y","volume":"13","author":"JH Cheong","year":"2022","unstructured":"Cheong JH, et al. Development and validation of a prognostic and predictive 32-gene signature for gastric cancer. Nat Commun. 2022;13(1):774.","journal-title":"Nat Commun"},{"issue":"1","key":"4437_CR39","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12967-023-03921-1","volume":"21","author":"Q Zhou","year":"2023","unstructured":"Zhou Q, et al. Cancer functional states-based molecular subtypes of gastric cancer. J Transl Med. 2023;21(1):80.","journal-title":"J Transl Med"},{"key":"4437_CR40","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/bs.acr.2021.02.006","volume":"151","author":"WM Grady","year":"2021","unstructured":"Grady WM. Epigenetic alterations in the gastrointestinal tract: Current and emerging use for biomarkers of cancer. Adv Cancer Res. 2021;151:425\u201368.","journal-title":"Adv Cancer Res"},{"issue":"1","key":"4437_CR41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13148-023-01478-w","volume":"15","author":"S Weng","year":"2023","unstructured":"Weng S, et al. Epigenetically regulated gene expression profiles decipher four molecular subtypes with prognostic and therapeutic implications in gastric cancer. Clin Epigenetics. 2023;15(1):64.","journal-title":"Clin Epigenetics"},{"issue":"16","key":"4437_CR42","doi-asserted-by":"publisher","first-page":"2898","DOI":"10.1038\/s41388-021-01743-3","volume":"40","author":"Y Chen","year":"2021","unstructured":"Chen Y, et al. Classifying gastric cancer using FLORA reveals clinically relevant molecular subtypes and highlights LINC01614 as a biomarker for patient prognosis. Oncogene. 2021;40(16):2898\u2013909.","journal-title":"Oncogene"},{"issue":"1","key":"4437_CR43","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1038\/s41598-021-00410-7","volume":"11","author":"L Li","year":"2021","unstructured":"Li L, Ma J. Molecular characterization of metabolic subtypes of gastric cancer based on metabolism-related lncRNA. Sci Rep. 2021;11(1):21491.","journal-title":"Sci Rep"},{"key":"4437_CR44","doi-asserted-by":"publisher","first-page":"1024985","DOI":"10.3389\/fonc.2022.1024985","volume":"12","author":"Y Ye","year":"2022","unstructured":"Ye Y, et al. Metabolism-associated molecular classification of gastric adenocarcinoma. Front Oncol. 2022;12:1024985.","journal-title":"Front Oncol"},{"issue":"8","key":"4437_CR45","doi-asserted-by":"publisher","first-page":"688","DOI":"10.5306\/wjco.v12.i8.688","volume":"12","author":"M Ramos","year":"2021","unstructured":"Ramos M, et al. Gastric cancer molecular classification based on immunohistochemistry and in situ hybridization: Analysis in western patients after curative-intent surgery. World J Clin Oncol. 2021;12(8):688\u2013701.","journal-title":"World J Clin Oncol"},{"issue":"1","key":"4437_CR46","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1002\/cac2.12516","volume":"44","author":"FH Wang","year":"2023","unstructured":"Wang FH, et al. The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023. Cancer Commun. 2023;44(1):127\u201372.","journal-title":"Cancer Commun"},{"key":"4437_CR47","doi-asserted-by":"publisher","first-page":"1588950","DOI":"10.3389\/fonc.2025.1588950","volume":"15","author":"G Dong","year":"2025","unstructured":"Dong G, et al. Case Report: Dramatic response to entritinib in a patient with gastrointestinal stromal tumor positive for NTRK3 fusion. Front Oncol. 2025;15:1588950.","journal-title":"Front Oncol"},{"key":"4437_CR48","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1200\/JCO.2023.41.4_suppl.441","volume":"41","author":"M Hong","year":"2023","unstructured":"Hong M, et al. Clinical application of circulating tumor DNA (ctDNA) in patients with metastatic gastric cancer. J Clin Oncol. 2023;41:441\u2013441.","journal-title":"J Clin Oncol"},{"issue":"5","key":"4437_CR49","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1007\/s10120-025-01621-x","volume":"28","author":"M He","year":"2025","unstructured":"He M, et al. Circulating tumor DNA predicts clinical benefits of immune checkpoint blockade in HER2-negative patients with advanced gastric cancer. Gastric Cancer. 2025;28(5):872\u201385.","journal-title":"Gastric Cancer"},{"issue":"8","key":"4437_CR50","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1136\/gutjnl-2024-333657","volume":"74","author":"X Guo","year":"2025","unstructured":"Guo X, et al. Diagnostic efficacy of an extracellular vesicle-derived lncRNA-based liquid biopsy signature for the early detection of early-onset gastric cancer. Gut. 2025;74(8):1209\u201318.","journal-title":"Gut"},{"key":"4437_CR51","doi-asserted-by":"crossref","unstructured":"Tian Y, et al. Functional and clinical validation of tsRNA-defined molecular subtypes guides precision therapy in gastric cancer. Front Immunol. 2025;16:1684113.","DOI":"10.3389\/fimmu.2025.1684113"},{"issue":"1","key":"4437_CR52","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1038\/s41467-018-03121-2","volume":"9","author":"S Ge","year":"2018","unstructured":"Ge S, et al. A proteomic landscape of diffuse-type gastric cancer. Nat Commun. 2018;9(1):1012.","journal-title":"Nat Commun"},{"issue":"1","key":"4437_CR53","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/s41467-023-35797-6","volume":"14","author":"W Shi","year":"2023","unstructured":"Shi W, et al. Multilevel proteomic analyses reveal molecular diversity between diffuse-type and intestinal-type gastric cancer. Nat Commun. 2023;14(1):835.","journal-title":"Nat Commun"},{"issue":"31","key":"4437_CR54","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.2217\/fon-2021-0398","volume":"17","author":"A Topcu","year":"2021","unstructured":"Topcu A, et al. Efficacy of Trastuzumab and Potential Risk Factors on Survival in Patients with HER2-Positive Metastatic Gastric Cancer. Future Oncol. 2021;17(31):4157\u201369.","journal-title":"Future Oncol"},{"key":"4437_CR55","doi-asserted-by":"crossref","unstructured":"Ma Y, et al. Current development of molecular classifications of gastric cancer based on omics (Review). Int J Oncol. 2024;65(3):89.","DOI":"10.3892\/ijo.2024.5677"},{"issue":"3","key":"4437_CR56","doi-asserted-by":"publisher","first-page":"183","DOI":"10.5230\/jgc.2015.15.3.183","volume":"15","author":"JK Choi","year":"2015","unstructured":"Choi JK, et al. Clinical Relevance of the Tumor Location-Modified Lauren Classification System of Gastric Cancer. J Gastric Cancer. 2015;15(3):183.","journal-title":"J Gastric Cancer"},{"issue":"1","key":"4437_CR57","doi-asserted-by":"publisher","first-page":"813","DOI":"10.3390\/ijms24010813","volume":"24","author":"M Salati","year":"2023","unstructured":"Salati M, et al. Clinical Significance of Molecular Subtypes in Western Advanced Gastric Cancer: A Real-World Multicenter Experience. Int J Mol Sci. 2023;24(1):813.","journal-title":"Int J Mol Sci"},{"key":"4437_CR58","doi-asserted-by":"crossref","unstructured":"Zeng C, et al. Identification of TGF-\u03b2 signaling-related molecular patterns, construction of a prognostic model, and prediction of immunotherapy response in gastric cancer. Front Pharmacol. 2022;13:1069204.","DOI":"10.3389\/fphar.2022.1069204"},{"key":"4437_CR59","doi-asserted-by":"crossref","unstructured":"Zhu C, et al. Prediction of prognosis, immunogenicity and efficacy of immunotherapy based on cholesterol metabolism in gastric cancer. Front Oncol. 2024;14:1518010.","DOI":"10.3389\/fonc.2024.1518010"},{"issue":"1","key":"4437_CR60","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12916-025-04575-0","volume":"24","author":"K Jia","year":"2026","unstructured":"Jia K, et al. Impact of Helicobacter pylori infection on gut and intratumoral microbiome and its association with immunotherapy response in gastrointestinal cancer. BMC Med. 2026;24(1):79.","journal-title":"BMC Med"},{"key":"4437_CR61","doi-asserted-by":"crossref","unstructured":"Liang C, et al. Therapeutic efficacy of multiple neoadjuvant regimens involving targeted therapy, immunotherapy and chemotherapy in gastric cancer: a systematic review and meta-analysis. BMC Cancer. 2025;25(1):1694.","DOI":"10.1186\/s12885-025-15136-2"},{"issue":"5","key":"4437_CR62","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s10120-024-01523-4","volume":"27","author":"A Ooki","year":"2024","unstructured":"Ooki A, et al. Potent therapeutic strategy in gastric cancer with microsatellite instability-high and\/or deficient mismatch repair. Gastric Cancer. 2024;27(5):907\u201331.","journal-title":"Gastric Cancer"},{"issue":"9","key":"4437_CR63","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1016\/j.trecan.2024.06.007","volume":"10","author":"TR de Back","year":"2024","unstructured":"de Back TR, et al. Transcriptomic subtyping of gastrointestinal malignancies. Trends Cancer. 2024;10(9):842\u201356.","journal-title":"Trends Cancer"},{"issue":"3","key":"4437_CR64","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.chom.2024.02.004","volume":"32","author":"S Wong","year":"2024","unstructured":"Wong S, Tan P. A tough act to swallow: Streptococcus anginosus and gastric cancer. Cell Host Microbe. 2024;32(3):291\u20133.","journal-title":"Cell Host Microbe"},{"key":"4437_CR65","doi-asserted-by":"publisher","first-page":"112931","DOI":"10.1016\/j.ejca.2023.05.019","volume":"189","author":"K Jia","year":"2023","unstructured":"Jia K, et al. Multidimensional immune profiling in Gastric Cancer Multiplex Immunohistochemistry Atlas from Peking University Cancer Hospital project informs PD-1\/PD-L1 blockade efficacy. Eur J Cancer. 2023;189:112931.","journal-title":"Eur J Cancer"},{"key":"4437_CR66","doi-asserted-by":"publisher","first-page":"5593","DOI":"10.1158\/1538-7445.AM2023-5593","volume":"83","author":"N McCafferty","year":"2023","unstructured":"McCafferty N, et al. Abstract 5593: Clonal mutation burden and evolutionary dynamics analysis in metastatic gastro-esophageal adenocarcinoma (GEA) by error corrected whole-exome circulating tumor DNA sequencing. Cancer Res. 2023;83:5593\u20135593.","journal-title":"Cancer Res"},{"key":"4437_CR67","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1158\/1538-7445.AM2018-1037","volume":"78","author":"JE Lee","year":"2018","unstructured":"Lee JE, et al. Abstract 1037: Comprehensive molecular profiles of gastric cancer patient derived xenograft (PDX) models and its implication in precision cancer medicine. Cancer Res. 2018;78:1037\u20131037.","journal-title":"Cancer Res"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04437-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04437-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:07:39Z","timestamp":1785521259000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04437-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4437"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04437-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"314"}}